Michael Morcos

4.3k total citations · 2 hit papers
41 papers, 2.5k citations indexed

About

Michael Morcos is a scholar working on Clinical Biochemistry, Aging and Molecular Biology. According to data from OpenAlex, Michael Morcos has authored 41 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Clinical Biochemistry, 10 papers in Aging and 9 papers in Molecular Biology. Recurrent topics in Michael Morcos's work include Genetics, Aging, and Longevity in Model Organisms (10 papers), Advanced Glycation End Products research (10 papers) and Circadian rhythm and melatonin (4 papers). Michael Morcos is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (10 papers), Advanced Glycation End Products research (10 papers) and Circadian rhythm and melatonin (4 papers). Michael Morcos collaborates with scholars based in Germany, United States and Portugal. Michael Morcos's co-authors include Peter P. Nawroth, Angelika Bierhaus, Per M. Humpert, Thoralf Wendt, David M. Stern, Triantafyllos Chavakis, Bernd Arnold, Gottfried Rudofsky, Maximilian von Eynatten and Markus Schwaninger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Diabetes Care and Kidney International.

In The Last Decade

Michael Morcos

39 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Understanding RAGE, the receptor for advanced glycation end products

2005 1.0k citations Angelika Bierhaus, Per M. Humpert et al. profile →
A mechanism converting psychosocial stress into mononuclear cell activation

2003 692 citations Angelika Bierhaus, Per M. Humpert et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael Morcos	1.0k	531	489	406	354	41	2.5k
Anjana Bali	503 0.5×	512 1.0×	518 1.1×	626 1.5×	328 0.9×	56	2.5k
Per M. Humpert	1.6k 1.5×	1.0k 1.9×	1.0k 2.1×	849 2.1×	372 1.1×	71	4.8k
Thoralf Wendt	2.9k 2.9×	1.4k 2.7×	983 2.0×	640 1.6×	349 1.0×	33	4.8k
Emre Sarandöl	306 0.3×	258 0.5×	286 0.6×	248 0.6×	368 1.0×	69	2.0k
Bilal Üstündağ	130 0.1×	446 0.8×	524 1.1×	680 1.7×	376 1.1×	104	4.0k
Li‐Tung Huang	93 0.1×	386 0.7×	845 1.7×	1.1k 2.7×	290 0.8×	195	5.1k
Pedro Montilla	101 0.1×	353 0.7×	475 1.0×	463 1.1×	90 0.3×	78	2.3k
Ömer Akyol	93 0.1×	124 0.2×	555 1.1×	338 0.8×	257 0.7×	71	2.6k
Elena Vara	63 0.1×	455 0.9×	663 1.4×	763 1.9×	129 0.4×	156	3.0k
León Ferder	145 0.1×	885 1.7×	1.2k 2.5×	1.0k 2.5×	93 0.3×	105	4.8k

Countries citing papers authored by Michael Morcos

Since Specialization

Citations

This map shows the geographic impact of Michael Morcos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Morcos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Morcos more than expected).

Fields of papers citing papers by Michael Morcos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Morcos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Morcos. The network helps show where Michael Morcos may publish in the future.

Co-authorship network of co-authors of Michael Morcos

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Morcos. A scholar is included among the top collaborators of Michael Morcos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Morcos. Michael Morcos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morcos, Michael, et al.. (2025). A central role of nutrition in cognitive function among primary school children: a cross-sectional analysis. BMC Nutrition. 11(1). 35–35.

Morcos, Michael, et al.. (2024). Impact of Covid-19 lockdowns on the anthropometric development in primary school children in the Rhein-Neckar Region, Germany. BMC Nutrition. 10(1). 78–78. 2 indexed citations

Kolibabka, M, Johann Gassenhuber, Nadine Dietrich, et al.. (2023). The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy. Acta Diabetologica. 60(11). 1551–1565. 10 indexed citations

Fleming, Thomas, et al.. (2018). Plate-based Large-scale Cultivation of <em>Caenorhabditis elegans</em>: Sample Preparation for the Study of Metabolic Alterations in Diabetes. Journal of Visualized Experiments. 5 indexed citations

Mendler, Michael, Andrea Schlotterer, Nadine Volk, et al.. (2016). Reduction in ins-7 gene expression in non-neuronal cells of high glucose exposed Caenorhabditis elegans protects from reactive metabolites, preserves neuronal structure and head motility, and prolongs lifespan. Journal of Diabetes and its Complications. 31(2). 304–310. 8 indexed citations

Mendler, Michael, Andreas Schlotterer, Youssef Ibrahim, et al.. (2014). daf-16/FOXO and glod-4/glyoxalase-1 are required for the life-prolonging effect of human insulin under high glucose conditions in Caenorhabditis elegans. Diabetologia. 58(2). 393–401. 28 indexed citations

Oikonomou, Dimitrios, Stefan Kopf, Zdenka Djuric, et al.. (2014). Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study. Cardiovascular Diabetology. 13(1). 137–137. 19 indexed citations

Schlotterer, Andreas, Andreas Hamann, G Kukudov, et al.. (2010). Apurinic/apyrimidinic endonuclease 1, p53, and thioredoxin are linked in control of aging inC. elegans. Aging Cell. 9(3). 420–432. 22 indexed citations

Morath, Christian, Bruno M. Schmied, Arianeb Mehrabi, et al.. (2009). Angiotensin‐converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation. Clinical Transplantation. 23(s21). 33–36. 5 indexed citations

10.

Morath, Christian, Bruno M. Schmied, Arianeb Mehrabi, et al.. (2009). Simultaneous pancreas–kidney transplantation in type 1 diabetes. Clinical Transplantation. 23(s21). 115–120. 21 indexed citations

11.

Humpert, Per M., Michael Morcos, Dimitrios Oikonomou, et al.. (2009). External Electric Muscle Stimulation Improves Burning Sensations and Sleeping Disturbances in Patients with Type 2 Diabetes and Symptomatic Neuropathy. Pain Medicine. 10(2). 413–419. 19 indexed citations

12.

Morcos, Michael, Andrea Schlotterer, G Kukudov, et al.. (2008). Rosiglitazone Reduces Angiotensin II and Advanced Glycation End Product-dependent Sustained Nuclear Factor-κB Activation in Cultured Human Proximal Tubular Epithelial Cells. Hormone and Metabolic Research. 40(11). 752–759. 25 indexed citations

13.

Humpert, Per M., Zdenka Djuric, Stefan Kopf, et al.. (2007). Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes. Cardiovascular Diabetology. 6(1). 9–9. 101 indexed citations

14.

Rudofsky, Gottfried, Andrea Schlotterer, Per M. Humpert, et al.. (2007). A M55V Polymorphism in the SUMO4 Gene is Associated with a Reduced Prevalence of Diabetic Retinopathy in Patients with Type 1 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 116(1). 14–17. 5 indexed citations

15.

Humpert, Per M., Stefan Kopf, Zdenka Djuric, et al.. (2006). Plasma sRAGE Is Independently Associated With Urinary Albumin Excretion in Type 2 Diabetes. Diabetes Care. 29(5). 1111–1113. 37 indexed citations

16.

Korosoglou, Grigorios, Per M. Humpert, Raffi Bekeredjian, et al.. (2006). Evidence of Left Ventricular Contractile Asynchrony by Echocardiographic Phase Imaging in Patients With Type 2 Diabetes Mellitus and Without Clinically Evident Heart Disease. The American Journal of Cardiology. 98(11). 1525–1530. 27 indexed citations

17.

Hamann, A., Michael Morcos, & Peter P. Nawroth. (2004). Orale Diabetestherapie. Der Internist. 45(12). 1356–1363. 1 indexed citations

18.

Hofmann, M., Stephan Schiekofer, Berend Isermann, et al.. (1999). Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB. Diabetologia. 42(2). 222–232. 154 indexed citations

19.

Morcos, Michael, et al.. (1998). Autoantibodies to polymorphonuclear neutrophil elastase do not inhibit but enhance elastase activity. American Journal of Kidney Diseases. 31(6). 978–985. 10 indexed citations

20.

Morcos, Michael, et al.. (1994). Human glomerular mesangial cells express CD16 and may be stimulated via this receptor. Kidney International. 46(6). 1627–1634. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact